Article Information
vol. 69 no. 4 884-887
PubMed
Print ISSN
Online ISSN
History
- Accepted December 29, 2020
- Published online April 1, 2021.
Article Versions
- Previous version (March 23, 2021 - 05:08).
- You are viewing the most recent version of this article.
Copyright & Usage
© American Federation for Medical Research 2021. No commercial re-use. See rights and permissions. Published by BMJ. This article is made freely available for use in accordance with BMJ’s website terms and conditions for the duration of the covid-19 pandemic or until otherwise determined by BMJ. You may use, download and print the article for any lawful, non-commercial purpose (including text and data mining) provided that all copyright notices and trade marks are retained.https://bmj.com/coronavirus/usage
Author Information
- Claudio Carallo1,
- Fabiola Pugliese2,
- Elisa Vettorato2,
- Cesare Tripolino3,
- Livia Delle Donne2,
- Giovanni Guarrera4,
- Walter Spagnolli5,
- Susanna Cozzio2
- 1 Metabolic Diseases Unit, Department of Clinical and Experimental Medicine, Magna Græcia University, Catanzaro, Italy
- 2 High Intensity Internal Medicine Unit, Santa Maria del Carmine Hospital, Rovereto, Italy
- 3 Department of Internal Medicine, Ospedale Maggiore Carlo Alberto Pizzardi, Bologna, Italy
- 4 APSS PA Trento, Trento, Italy
- 5 Internal Medicine Unit, Santa Chiara Hospital, Trento, Italy
- Correspondence to Dr Claudio Carallo, Catanzaro, Italy; numemaca{at}yahoo.it
Article usage
Statistics from Altmetric.com
Vol 69 Issue 4
Table of Contents
Higher heparin dosages reduce thromboembolic complications in patients with COVID-19 pneumonia
Respond to this article